While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

According to research published in JAMA Network Open, the use of anti-obesity medications, including glucagon-like peptide-1 ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...

GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription ...

A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...

The emergence and development of glucagon-like Peptide-1 agonists (GLP-1s) is the primary trend of interest in the ...